SWTX

SpringWorks Therapeutics
SWTX

Overview Fund Activity
Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

225 hedge funds and large institutions have $2.58B invested in SpringWorks Therapeutics in 2024 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 90 increasing their positions, 61 reducing their positions, and 23 closing their positions.

Holders
225
Holders Change
+16
Holders Change %
+7.66%
% of All Funds
3.26%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
40
Increased
90
Reduced
61
Closed
23
Calls
$4.46M
Puts
$9.02M
Net Calls
-$4.56M
Net Calls Change
+$5.64M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$39.3M
2
Morgan Stanley
2
Morgan Stanley
New York
$46.1M
3
PCH
3
Polar Capital Holdings
United Kingdom
$48.1M
4
Principal Financial Group
4
Principal Financial Group
Iowa
$29.4M
5
CCM
5
Cutter Capital Management
New York
$12.1M

Top Sellers

1
AG
1
Artal Group
Luxembourg
$0
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$34.3M
3
PA
3
Perceptive Advisors
New York
$22.2M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$62.9M
5
O
5
OrbiMed
New York
$44.6M
Name Market Value Shares Shares
Change 		Shares
Change %
IC
251
Ikarian Capital
Texas
– – – –
C
252
Covestor
United Kingdom
$0 4 – –
7 8 9 10
11